CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma

Increased CCL5 levels are markers of an unfavourable outcome in patients with melanoma, breast, cervical, prostate, gastric or pancreatic cancer. Here, we have assessed the role played by CCL5/CCR5 interactions in the development of colon cancer. To do so, we have examined a number of human colorectal carcinoma clinical specimens and found CCL5 and its receptors over-expressed within primary as well as liver and pulmonary metastases of patients compared to healthy tissues. In vitro, CCL5 increased the growth and migratory responses of colon cancer cells from both human and mouse origins. In addition, systemic treatment of mice with CCL5-directed antibodies reduced the extent of development of subcutaneous colon tumors, of liver metastases and of peritoneal carcinosis. Consistently, we found increased numbers of CD45-immunoreactive cells within the stroma of the remaining lesions as well as at the interface with the healthy tissue. In contrast, selective targeting of CCR5 through administration of TAK-779, a CCR5 antagonist, only partially compromised colon cancer progression. Furthermore, CCL5 neutralization rendered the tumors more sensitive to a PDGFRβ-directed strategy in mice, this combination regimen offering the greatest protection against liver metastases and suppressing macroscopic peritoneal carcinosis. Collectively, our data demonstrate the involvement of CCL5 in the pathogenesis of colorectal carcinoma and point to its potential value as a therapeutic target.

• Publication year

  2011

• Venue

  PLoS ONE

• Publication date

  2011-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0028842PMID 22205974PMCID 3243667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.

  2011cited by this paper
• Targeting non-malignant disorders with tyrosine kinase inhibitors

  2010cited by this paper
• Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents.

  2010cited by this paper
• Invasion associated up‐regulation of nuclear factor κB target genes in colorectal cancer

  2009cited by this paper
• Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism

  2009influential reference
• DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.

  2009influential reference
• Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1

  2009influential reference
• Expression of chemokines and chemokine receptors in human colon cancer.

  2009cited by this paper
• Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs

  2009cited by this paper
• PDGFRα/β expression correlates with the metastatic behavior of human colorectal cancer: A possible rationale for a molecular targeting strategy

  2008cited by this paper
• PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.

  2008cited by this paper
• Gastric cancer cells exploit CD4+ cell‐derived CCL5 for their growth and prevention of CD8+ cell‐involved tumor elimination

  2008cited by this paper
• Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy

  2008cited by this paper
• Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.

  2006cited by this paper
• Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma

  2006cited by this paper
• Tumor stroma and regulation of cancer development.

  2006cited by this paper
• Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer

  2006cited by this paper
• Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.

  2006cited by this paper
• Expression of CCL5 (RANTES) and CCR5 in prostate cancer

  2006cited by this paper
• The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients

  2006cited by this paper
• A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma.

  2006cited by this paper
• Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma

  2005cited by this paper
• Chemokines in tumor progression and metastasis

  2005influential reference
• PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.

  2004cited by this paper
• Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors.

  2004cited by this paper
• Neurons and Astrocytes Respond to Prion Infection by Inducing Microglia Recruitment

  2004cited by this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cited by this paper
• The discovery of receptor tyrosine kinases: targets for cancer therapy

  2004cited by this paper
• Friends or foes — bipolar effects of the tumour stroma in cancer

  2004cited by this paper
• PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

  2003cited by this paper
• Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

  2003cited by this paper
• Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinoma

  2003cited by this paper
• Involvement of platelet-derived growth factor in disease: development of specific antagonists.

  2001cited by this paper
• Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.

  2001cited by this paper
• Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.

  2001cited by this paper
• Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

  2000cited by this paper
• Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

  1999cited by this paper
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

  1999cited by this paper
• Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors

  1998cited by this paper
• Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.

  1998cited by this paper
• Expression in lung carcinomas of platelet-derived growth factor and its receptors.

  1997cited by this paper
• Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma.

  1996cited by this paper
• Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.

  1995cited by this paper
• Platelet-derived growth factor is angiogenic in vivo.

  1992cited by this paper
• Prognostic markers of colorectal cancer: An evaluation of DNA content, epidermal growth factor receptor, and Ki‐67

  1992cited by this paper
• The origin and function of tumor-associated macrophages.

  1992cited by this paper
• Expression of several growth factors and their receptor genes in human colon carcinomas

  1990cited by this paper

• Tertiary lymphoid structures are associated with enhanced macrophage activation and immune checkpoint expression, and predict outcome in cervical cancer.

  2025cites this paper
• Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival

  2025cites this paper
• Author Correction: Alcohol consumption promotes colorectal carcinoma metastasis via a CCL5-induced and AMPK-pathway-mediated activation of autophagy

  2025cites this paper
• C-C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology.

  2025cites this paper
• Could Silent Inflammation Originating in Jawbone Cavitations Play a Role in Activating the CCL5/CCR5 Axis in Female Breast Cancer? A Diagnostic and Therapeutic Gap in Osteoimmunological Interactions

  2025cites this paper
• Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment.

  2024cites this paper
• Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies

  2024cites this paper
• CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

  2024cites this paper
• Tertiary lymphoid structures are associated with enhanced macrophage and dendritic cell

  2023cites this paper
• Derivation of CD8+ T cell infiltration potentiators in non-small-cell lung cancer through tumor microenvironment analysis

  2023cites this paper
• 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates

  2023cites this paper
• The regulatory network of the chemokine CCL5 in colorectal cancer

  2023cites this paper
• Vagus innervation in the gastrointestinal tumor: Current understanding and challenges.

  2023cites this paper
• Macrophage-Based Therapeutic Strategies in Hematologic Malignancies

  2023cites this paper
• A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer

  2022cites this paper
• Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study

  2022cites this paper
• Chemokines in colon cancer progression.

  2022cites this paper
• E6/E7 from Beta-2-HPVs 122, 38b, and 107 possess transforming properties in a fibroblast model in vitro.

  2022cites this paper
• Role of chemokine systems in cancer and inflammatory diseases

  2022cites this paper
• Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas

  2022cites this paper
• Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer

  2022cites this paper
• Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma

  2021cites this paper
• Myeloid Immune Cells CARrying a New Weapon Against Cancer

  2021cites this paper
• Hub Genes Related to the Pathogenesis and Progression of Colorectal Cancer and Adenoma by Integrative Bioinformatics Approaches

  2021cites this paper
• Potential Role of Diabetes Mellitus-Associated T Cell Senescence in Epithelial Ovarian Cancer Omental Metastasis

  2021cites this paper
• Macrophage-Based Approaches for Cancer Immunotherapy A C

  2021cites this paper
• An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5

  2021cites this paper
• CCR5 is a potential therapeutic target for cancer

  2021influential citation
• Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice

  2021cites this paper
• Research trends in pharmacological modulation of tumor‐associated macrophages

  2021cites this paper
• Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis

  2020cites this paper
• The G protein coupled receptor CCR5 in cancer.

  2020cites this paper
• The Emergence of the Next-Generation Vaccines

  2020cites this paper
• Macrophage-Based Approaches for Cancer Immunotherapy

  2020cites this paper
• The CCL5/CCR5 Axis in Cancer Progression

  2020cites this paper
• CircABCB10 silencing inhibits the cell ferroptosis and apoptosis by regulating the miR-326/CCL5 axis in rectal cancer.

  2020influential citation
• Temperature-Sensitive Amphiphilic Non-Ionic Triblock Copolymers for Enhanced In Vivo Skeletal Muscle Transfection.

  2020cites this paper
• CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment

  2020cites this paper
• CCL5 mediates CD40-driven CD4+ T-cell tumor infiltration and immunity.

  2020cites this paper
• Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells

  2020cites this paper
• Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma

  2020cites this paper
• Role of Innate Immunity in Cancers and Antitumor Response

  2020cites this paper
• Recent Advances targeting CCR5 for Cancer and its Role in Immuno-Oncology.

  2019cites this paper
• CCR5 status and metastatic progression in colorectal cancer

  2019cites this paper
• The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer

  2019influential citation
• A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

  2019cites this paper
• Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study

  2019cites this paper
• Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor-associated macrophages

  2019cites this paper
• Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme

  2019cites this paper
• Identification of a novel biomarker-CCL5 using antibody microarray for colorectal cancer.

  2019cites this paper
• Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5

  2019cites this paper
• Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets

  2019cites this paper
• Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth

  2019cites this paper
• Identification of key genes and pathways in seminoma by bioinformatics analysis

  2019cites this paper
• [Nanotaxi® for RNA or DNA vaccines].

  2019cites this paper
• Tuning the Tumor Myeloid Microenvironment to Fight Cancer

  2019cites this paper
• Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis

  2018cites this paper
• CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ

  2018cites this paper
• CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells

  2018cites this paper
• The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer

  2018cites this paper
• MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth

  2018cites this paper
• Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection

  2018cites this paper
• Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis

  2018cites this paper
• Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression

  2018cites this paper
• Alcohol consumption promotes colorectal carcinoma metastasis via a CCL5-induced and AMPK-pathway-mediated activation of autophagy

  2018cites this paper
• Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer

  2018cites this paper
• C-C motif chemokine receptors in gastric cancer.

  2017cites this paper
• Human MSCs promotes colorectal cancer epithelial–mesenchymal transition and progression via CCL5/β-catenin/Slug pathway

  2017cites this paper
• Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis

  2017cites this paper
• Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model

  2017cites this paper
• SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators

  2017cites this paper
• Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy

  2017cites this paper
• Onkogenes Schlüsselsignal RANTES/CCL5 – „Cytokine Cross Talk“ des Tumors und „Silent Inflammation“ des Kieferknochens

  2017cites this paper
• Mediadores inflamatorios y su influencia en la evolución del cáncer colorrectal

  2017cites this paper
• Process of hepatic metastasis from pancreatic cancer: biology with clinical significance

  2016cites this paper
• Novel grooved substrata stimulate macrophage fusion, CCL2 and MMP-9 secretion.

  2016cites this paper
• Contribution of complement anaphylatoxin receptors to melanoma growth: potential therapeutic targets

  2016cites this paper
• Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes

  2016cites this paper
• Management of the Primary Tumor in Metastatic Colorectal Cancer

  2016cites this paper
• Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

  2016cites this paper
• Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.

  2016cites this paper
• C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.

  2016cites this paper
• Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

  2016cites this paper
• Cytokine Networks In Esophageal Squamous Cell Carcinoma

  2016cites this paper
• Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.

  2015cites this paper
• Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges

  2015cites this paper
• CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells

  2015cites this paper
• Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells

  2015cites this paper
• Clinical Study Circulating CCL 5 Levels in Patients with Breast Cancer : Is There a Correlation with Lymph Node Metastasis ?

  2015cites this paper
• CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.

  2015cites this paper
• Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.

  2015cites this paper
• RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth

  2015cites this paper
• The Inflammatory Chemokine CCL 5 and Cancer Progression

  2015cites this paper
• A Meta-Analysis to Determine the Effect of Primary Tumor Resection for Stage IV Colorectal Cancer with Unresectable Metastases on Patient Survival

  2014cites this paper
• A Meta-Analysis to Determine the Effect of Primary Tumor Resection for Stage IV Colorectal Cancer with Unresectable Metastases on Patient Survival

  2014cites this paper
• Pharmacological intervention at CCR1 and CCR5 as an approach for cancer: help or hindrance.

  2014cites this paper
• Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression

  2014cites this paper
• The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.

  2014cites this paper
• The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer

  2014influential citation
• The Inflammatory Chemokine CCL5 and Cancer Progression

  2014cites this paper